Optimal cancer-killing t cells discovered
A team of cancer researchers has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
Stay updated with breaking news from Kite Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A team of cancer researchers has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
A Special Report from the Fierce Biotech team on the state of cell therapy.
A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.